1340480-93-4 Usage
Uses
Used in Pharmaceutical Research:
(R)-4-((S)-2-((E)-3-(4-chlorophenyl)acrylamide)propanamide)-N1-((S)-1,6-diamino-1-oxohexan-2-yl)pentanediaMide is used as a potential drug candidate in pharmaceutical research due to its complex structure and the presence of functional groups that may exhibit biological activity.
Used in Drug Design and Development:
In the field of drug design and development, (R)-4-((S)-2-((E)-3-(4-chlorophenyl)acrylamide)propanamide)-N1-((S)-1,6-diamino-1-oxohexan-2-yl)pentanediaMide is utilized for its potential to bind with other molecules, which can be further explored to create new drugs with specific therapeutic effects.
Used in Chemical Synthesis:
(R)-4-((S)-2-((E)-3-(4-chlorophenyl)acrylamide)propanamide)-N1-((S)-1,6-diamino-1-oxohexan-2-yl)pentanediaMide can be employed as a key intermediate in the synthesis of other complex organic compounds, particularly in the development of novel pharmaceuticals and bioactive molecules.
Used in Analytical Chemistry:
(R)-4-((S)-2-((E)-3-(4-chlorophenyl)acrylaMido)propanaMido)-N1-((S)-1,6-diaMino-1-oxohexan-2-yl)pentanediaMide can also be used in analytical chemistry for the development of new methods and techniques for the detection and analysis of similar complex organic molecules, contributing to the advancement of chemical analysis and detection technologies.
Check Digit Verification of cas no
The CAS Registry Mumber 1340480-93-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,0,4,8 and 0 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1340480-93:
(9*1)+(8*3)+(7*4)+(6*0)+(5*4)+(4*8)+(3*0)+(2*9)+(1*3)=134
134 % 10 = 4
So 1340480-93-4 is a valid CAS Registry Number.
1340480-93-4Relevant academic research and scientific papers
CHEMICAL SYNTHESIS AND ANTI-TUMOR AND ANTI-METASTATIC EFFECTS OF DUAL FUNCTIONAL CONJUGATE
-
, (2017/10/24)
The present invention discloses chemical synthesis, anti-tumor and anti-metastatic effects of a dual functional conjugate as showed by formula I. In detail, paclitaxel or docetaxol is linked with muramyl dipeptide derivative to form a conjugate, thus dual anti-tumor and anti-metastatic effects are achieved by combination of chemotherapy and immunotherapy. The present invention also discloses that paclitaxel or docetaxol and muramyl dipeptide derivative conjugate is synthesized by combination of solid-phase and solution-phase synthesis, and said conjugate can be used in manufacture of anti-tumor medicaments as proved by reliable bioassays.
Solution-phase synthesis of a muramyl dipeptide analogue MDA
Zhao, Nan,Ma, Yao,Liu, Gang
, p. 1443 - 1446 (2012/06/04)
The solution-phase synthesis of a muramyl dipeptide (MDP) analogue of Nα-[4-chlorocinnamoyl-l-alanyl-d-isoglutaminyl]-l-lysine (MDA, 2) is reported that possesses the features of easy feasibility, safety and low cost in large scale of synthesis.
Conjugate (MTC-220) of muramyl dipeptide analogue and paclitaxel prevents both tumor growth and metastasis in mice
Ma, Yao,Zhao, Nan,Liu, Gang
experimental part, p. 2767 - 2777 (2011/06/23)
1 (MTC-220), a conjugate of paclitaxel and a muramyl dipeptide analogue, has been synthesized as a novel agent of dual antitumor growth and metastasis activities. In vitro and in vivo tests show that 1 retains its ability to inhibit tumor growth. It is su
